Medicaments for the treatment of toxoplasmosis
AssigneeGlaxo Wellcome Inc.
InventorAlan Thomas Hudson
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of 2-4-(4-chlorophenyl)cyclohexyl!-3-hydroxy-1,4-naphthoquinone or a physiologically acceptable salt or other physiologically funtional derivative thereof for the manufacture of a medicament for the treatment and/or prophylaxis of toxoplasmosis in animals, to pharmaceutical compositions for the treatment and/or prophylaxis of toxoplasmosis, comprising said compound as active ingredient and to a method of treating or preventing toxoplasmosis in an animal which comprises administering to said animal an effective amount of said compound.
Claims6
A method of treating toxoplasmosis in an animal which comprises administering to said animal suffering from toxoplasmosis an effective treatment amount of 2-4-(4-chlorophenyl)cyclohexyl!-3-hydroxy 1,4-naphthoquinone or a physiologically acceptable salt thereof.
Dependencies are inferred from the claim text.